Clinical Trial Update: Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating two-cycle and three-cycle induction therapy with a modified TPF chemotherapy regimen plus Camrelizumab for locally advanced na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Camrelizumab (camrelizumab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Nasopharyngeal Neoplasms, PD-1 Inhibitor | Phase 2 | Status: RECRUITING